Search results for "TLE"

showing 10 items of 2417 documents

Evaluation of Safety, Tolerability and Efficacy of Temsirolimus in Patients with Relapsed or Refractory Mantle Cell Lymphoma (Rel/Refr Mcl) in Routin…

2014

ABSTRACT Aim: Temsirolimus (TEMS), an mTOR-inhibitor, is approved in the EU for the treatment of patients (pts) with relapsed or refractory (rel/refr) MCL. A pivotal study demonstrated significantly longer progression free survival with TEMS (175 mg weekly for 3 weeks followed by 75 mg weekly) in rel/refr MCL pts compared to investigatoŕs choice therapy (4.8 mo vs 1.9 mo; P = .0009). To evaluate safety and efficacy of TEMS in an unselected patient population during clinical routine, a prospective non-interventional study with TEMS in rel/refr MCL pts is useful. Here we report on interim results of the study. Methods: A German multicenter registry for rel/refr MCL pts treated with TEMS was s…

medicine.medical_specialtybusiness.industryAnemiaHematologymedicine.diseaseTemsirolimusSurgeryOncologyRefractoryTolerabilityInternal medicineRefractory Mantle Cell LymphomaMedicineMantle cell lymphomaProgression-free survivalbusinessAdverse effectmedicine.drugAnnals of Oncology
researchProduct

Comparison of 2 Doses of Intravenous (IV) Temsirolimus (Temsr) in Patients with Relapsed/Refractory Mantle Cell Lymphoma (MCL)

2016

Abstract Introduction: Temsr (Torisel®) administered at 175 mg IV once weekly for first 3 weeks, followed by 75mg IV once weekly (Temsr 175/75 mg) is approved in the European Union for the treatment of adult patients with relapsed and/or refractory MCL based on an overall positive benefit-risk relationship demonstrated for this treatment regimen in the pivotal phase III study (Hess et al. J Clin Oncol. 2009;27:3822-9). This ongoing phase 4, multicenter, randomized, open-label study was conducted to explore whether similar efficacy can be achieved for the treatment of patients with relapsed/refractory MCL with a Temsr regimen that is expected to yield fewer side effects than the Temsr 175/75…

medicine.medical_specialtybusiness.industryImmunologyEcchymosisHazard ratioCell BiologyHematologyNeutropeniamedicine.diseaseBiochemistryGastroenterologySurgeryRegimenRefractoryInternal medicinemedicineClinical endpointmedia_common.cataloged_instanceMantle cell lymphomamedicine.symptomEuropean unionbusinessmedia_commonBlood
researchProduct

Reply: Sensory profile in primary restless legs syndrome and restless legs syndrome associated with small fibre neuropathy

2010

Sir, We wish to thank the editor for giving us the opportunity to respond to this letter. We appreciated reading that Drs Gemignani and Vitetta think our study (Bachmann et al. , 2010) provides support for the differential diagnosis of primary and secondary restless legs syndrome (RLS) associated with small fibre neuropathy, when comparing the sensory profiles of these groups of patients for the first time. Dr Gemignani recently wrote ‘A general consensus on the proposed criteria for the diagnosis of small fibre neuropathy has not been established’ (Gemignani, 2010 b ). This already applies for small fibre neuropathy without complicating RLS; however, for the constellation of RLS with small…

medicine.medical_specialtybusiness.industryShooting painSensory profilemedicine.diseaseComorbidity03 medical and health sciences0302 clinical medicinePhysical medicine and rehabilitationmental disordersSmall Fibre NeuropathymedicinePhysical therapyTingling030212 general & internal medicineNeurology (clinical)Restless legs syndromeDifferential diagnosisSecondary restless legs syndromebusiness030217 neurology & neurosurgeryBrain
researchProduct

Evaluation of Safety, Tolerability and Efficacy of Temsirolimus in Patients with Relapsed or Refractory Mantle Cell Lymphoma (REL/REFR MCL) in the Us…

2012

ABSTRACT Background Temsirolimus (TEMS), an mTOR-inhibitor, is approved the EU for the treatment of patients (pts) with relapsed or refractory MCL (rel/refr). A pivotal study demonstrated significantly longer progression free survival with TEMS (175mg weekly for 3 weeks followed by 75mg weekly) in rel/refr MCL pts compared to investigatoŕs choice therapy (4.8 mo vs 1.9 mo; P = .0009). To better identify safety and efficacy of TEMS in an unselected patient population during clinical routine a prospective non-interventional study with TEMS in rel/refr MCL-pts was started. Here we report on interim results of the study. Methods A registry for rel/refr MCL pts treated with TEMS was started in G…

medicine.medical_specialtybusiness.industrymacromolecular substancesHematologyTemsirolimusOncologyTolerabilityRefractoryInternal medicinemedicineRefractory Mantle Cell LymphomaIn patientProgression-free survivalLeukocytosismedicine.symptombusinessAdverse effectmedicine.drugAnnals of Oncology
researchProduct

Sleep–wake problems in patients with amyotrophic lateral sclerosis: implications for patient management

2012

SUMMARY Sleep–wake problems are frequent, although unrecognized, complications of amyotrophic lateral sclerosis (ALS). Sleep disorders such as insomnia, sleep-disordered breathing and restless legs syndrome have all been reported in patients with ALS, despite the limited number of studies and the small populations investigated so far. Sleep disturbances gradually worsen with disease progression, suggesting a relationship between the severity of disease and the neurodegenerative process. However, poor sleep can also be a consequence of several disturbances such as anxiety, depression, pain, choking, sialorrhea, fasciculations, cramps, nocturia and the inability to get comfortable and move f…

medicine.medical_specialtybusiness.industrymedicine.diseasePhysical medicine and rehabilitationExcessive daytime somnolencemedicineInsomniaNocturiaAnxietyNeurology (clinical)Restless legs syndromemedicine.symptomAmyotrophic lateral sclerosisChokingbusinessDepression (differential diagnoses)Neurodegenerative Disease Management
researchProduct

The “Jacobsen Flap” for the Treatment of Stage III–IV Dupuytren’s Disease at Little Finger: Our Review of 123 Cases

2011

For selective fasciectomy in patients with Dupuytren’s disease at Tubiana Stage I–II, midline longitudinal incisions with serial Z-plasties, Bruner zigzag incisions, and V-Y plasties over the palm and most severely affected fingers are accepted methods. Advantages of these approaches are good intraoperative visualization of the fibrous tissue, rapid dissection, minor tissue trauma, and usually the possibility of a tension-free wound closure (Brenner and Rayan 2003). In cases of Dupuytren’s disease at Stage III and IV, with severe digital flexion, inelastic overlying skin, and expected skin shortage after contracture release, these incisions may sometimes be useful, but in our experience, qu…

medicine.medical_specialtybusiness.industrymedicine.medical_treatmentWound BreakdownLittle fingermedicine.diseaseSurgeryDissectionmedicine.anatomical_structureComplex regional pain syndromeEdemamedicineSkin graftingStage (cooking)Contracturemedicine.symptombusiness
researchProduct

O071 : Telomerase reverse transcriptase mutations are associated with hepatocellular carcinoma in nash

2015

O071 TELOMERASE REVERSE TRANSCRIPTASE MUTATIONS ARE ASSOCIATED WITH HEPATOCELLULAR CARCINOMA IN NASH B. Donati, E. Vanni, P. Dongiovanni, M. Iavarone, R. Rametta, C. Rosso, A. Carnelutti, S. Petta, A.L. Fracanzani, H.L. Reeves, J.F. Dofour, L. Miele, Q. Anstee, E. Bugianesi, G. Soardo, S. Fargion, L. Valenti. Pathophysiology and Transplantation, Universita degli Studi di Milano, Milano, Medical Sciences, University of Turin, Turin, Internal Medicine, Gastroenterology, Fondazione IRCCS Ca’ Granda, Milano, Internal Medicine, University of Udine, Udine, Gastroenterology, University of Palermo, Palermo, Italy; Medicine, Freeman Hospital, Newcastle Upon Tyne, United Kingdom; Clinical Research, U…

medicine.medical_specialtyfood.ingredientHepatologybusiness.industryGeneral surgerymedicine.diseaseVirologyTransplantationfoodNewcastle upon tyneHepatocellular carcinomamedicinePettaTelomerase reverse transcriptasebusinessJournal of Hepatology
researchProduct

Effects of rectilinear acceleration and optokinetic and caloric stimulations in space.

1984

During the flight of Spacelab 1 the crew performed a number of experiments to explore changes in vestibular function and visual-vestibular interactions on exposure to microgravity. Measurements were made on the threshold for detection of linear oscillation, vestibulo-ocular reflexes elicited by angular and linear movements, oculomotor and posture responses to optokinetic stimulations, and responses to caloric stimulation. Tests were also conducted on the ground, during the 4 months before and on days 1 to 6 after flight. The most significant result was that caloric mystagmus of the same direction as on the earth could also be evoked in the weightless environment.

medicine.medical_specialtygenetic structuresEye MovementsMovementAccelerationCrewMotion PerceptionNystagmusAudiologyOpticsNystagmus PhysiologicWeightlessmedicineCaloric TestsHumansVestibular systemPhysicsMultidisciplinarymedicine.diagnostic_testbusiness.industryWeightlessnessWeightlessnessCaloric theoryOptokinetic reflexElectrooculographySpace FlightVestibular Function TestsElectrooculographyVisual Perceptionsense organsVestibule Labyrinthmedicine.symptombusinessHeadScience (New York, N.Y.)
researchProduct

European vestibular experiments on the Spacelab-1 mission: 1. Overview.

1986

During the flight of Spacelab-1 a series of vestibular experiments was performed on the crew by a group of European investigators. Control experiments were carried out on the same subjects pre- and postflight. The tests included caloric stimulation of the ears, threshold measurements of response to linear acceleration, motion sickness provocative stimuli, vestibulo-ocular reflexes during linear and angular stimulation, estimation of the subjective vertical (luminous line measurements) and static ocular counterrotation at various tilt angles. The caloric experiment proved the existence of a nonthermoconvective mechanism of caloric nystagmus in space. Most of the other test results point to a…

medicine.medical_specialtygenetic structuresMotion SicknessAccelerationCrewAudiologyAccelerationMotionOpticsmedicineCaloric TestsHumansOtolithPhysicsVestibular systemWeightlessnessbusiness.industryWeightlessnessGeneral NeuroscienceCaloric theoryReflex Vestibulo-OcularSpace Flightmedicine.diseaseAdaptation PhysiologicalSemicircular Canalsmedicine.anatomical_structureMotion sicknessVestibulesense organsVestibule LabyrinthbusinessExperimental brain research
researchProduct

2020

Introduction Adolescents have experienced decreased aerobic fitness levels and insufficient physical activity levels over the past decades. While both physical activity and aerobic fitness are related to physical and mental health, little is known concerning how they manifest in the brain during this stage of development, characterized by significant physical and psychosocial changes. The aim of the study is to examine the associations between both physical activity and aerobic fitness with brains' functional connectivity. Methods Here, we examined how physical activity and aerobic fitness are associated with local and interhemispheric functional connectivity of the adolescent brain (n = 59…

medicine.medical_specialtymedicine.diagnostic_testFunctional connectivity05 social sciencesPhysical activityBiology050105 experimental psychology03 medical and health sciencesBehavioral Neuroscience0302 clinical medicinePhysical medicine and rehabilitationmedicineAerobic exercise0501 psychology and cognitive sciencesFunctional magnetic resonance imagingPsychosocial030217 neurology & neurosurgeryShuttle run testBrain and Behavior
researchProduct